AmbAgon Therapeutics Funding: $103M Raised, Series A (2022)
AmbAgon Therapeutics is based in San Francisco, California. It has raised $103M in total funding. Latest round: Series A.
AmbAgon Therapeutics funding overview
AmbAgon Therapeutics is based in San Francisco, California. AmbAgon Therapeutics has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for AmbAgon Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Nextech Invest, RA Capital Management, Droia Ventures, INKEF Capital, AbbVie Ventures, MRL Ventures Fund and 2 others. 8 distinct backers are named across the disclosed rounds.
AmbAgon Therapeutics at a glance
Total raised
$103M
Latest round
Series A
Latest round date
January 2022
Headquarters
San Francisco, California
Notable investors
Nextech Invest, RA Capital Management, Droia Ventures, INKEF Capital, AbbVie Ventures, MRL Ventures Fund, Mission BioCapital, Surveyor Capital
Frequently asked about AmbAgon Therapeutics funding
How much has AmbAgon Therapeutics raised?
AmbAgon Therapeutics has raised $103M in total disclosed funding across the rounds on record.
Who has invested in AmbAgon Therapeutics?
Nextech Invest, RA Capital Management, Droia Ventures, INKEF Capital, AbbVie Ventures, MRL Ventures Fund are named among the investors backing AmbAgon Therapeutics.
What was the latest AmbAgon Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2022.
Where is AmbAgon Therapeutics based?
AmbAgon Therapeutics is based in San Francisco, California.
When did AmbAgon Therapeutics last raise?
The last disclosed AmbAgon Therapeutics round closed in January 2022 at Series A.
Round data for AmbAgon Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco and backer lists below.
